Mavacamten – a targeted therapy for hypertrophic cardiomyopathy

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiovascular pharmacology 2023-03
Hauptverfasser: Schenk, Ashley, Fields, Nathan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Journal of cardiovascular pharmacology
container_volume
creator Schenk, Ashley
Fields, Nathan
description
doi_str_mv 10.1097/FJC.0000000000001416
format Article
fullrecord <record><control><sourceid>wolterskluwer</sourceid><recordid>TN_cdi_wolterskluwer_health_00005344-990000000-00159</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>00005344-990000000-00159</sourcerecordid><originalsourceid>FETCH-wolterskluwer_health_00005344-990000000-001593</originalsourceid><addsrcrecordid>eNpjYJAxNNAzNLA013fzctYzQAKGJoZmLAycBoZmBrpGJiZmHAxcxcVZIHFTczNOBkffxLLE5MTcktQ8hUcNkxUSFUoSi9JTS1JTFEoyUosSCyoV0vKLFDIqC1KLSoryCzIykxWSE4tSMvNzK_MLEksyKnkYWNMSc4pTeaE0N4OJm2uIs4dueX5OSWpRcXZOaXlqUXxGamJOSUY8yEmmxiYmupaWUAfqAt1iamlMpjYAJ3ZHzw</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Mavacamten – a targeted therapy for hypertrophic cardiomyopathy</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Schenk, Ashley ; Fields, Nathan</creator><creatorcontrib>Schenk, Ashley ; Fields, Nathan</creatorcontrib><identifier>ISSN: 0160-2446</identifier><identifier>DOI: 10.1097/FJC.0000000000001416</identifier><language>eng</language><publisher>Journal of Cardiovascular Pharmacology</publisher><ispartof>Journal of cardiovascular pharmacology, 2023-03</ispartof><rights>Journal of Cardiovascular Pharmacology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Schenk, Ashley</creatorcontrib><creatorcontrib>Fields, Nathan</creatorcontrib><title>Mavacamten – a targeted therapy for hypertrophic cardiomyopathy</title><title>Journal of cardiovascular pharmacology</title><issn>0160-2446</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNpjYJAxNNAzNLA013fzctYzQAKGJoZmLAycBoZmBrpGJiZmHAxcxcVZIHFTczNOBkffxLLE5MTcktQ8hUcNkxUSFUoSi9JTS1JTFEoyUosSCyoV0vKLFDIqC1KLSoryCzIykxWSE4tSMvNzK_MLEksyKnkYWNMSc4pTeaE0N4OJm2uIs4dueX5OSWpRcXZOaXlqUXxGamJOSUY8yEmmxiYmupaWUAfqAt1iamlMpjYAJ3ZHzw</recordid><startdate>20230306</startdate><enddate>20230306</enddate><creator>Schenk, Ashley</creator><creator>Fields, Nathan</creator><general>Journal of Cardiovascular Pharmacology</general><scope/></search><sort><creationdate>20230306</creationdate><title>Mavacamten – a targeted therapy for hypertrophic cardiomyopathy</title><author>Schenk, Ashley ; Fields, Nathan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-wolterskluwer_health_00005344-990000000-001593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schenk, Ashley</creatorcontrib><creatorcontrib>Fields, Nathan</creatorcontrib><jtitle>Journal of cardiovascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schenk, Ashley</au><au>Fields, Nathan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mavacamten – a targeted therapy for hypertrophic cardiomyopathy</atitle><jtitle>Journal of cardiovascular pharmacology</jtitle><date>2023-03-06</date><risdate>2023</risdate><issn>0160-2446</issn><pub>Journal of Cardiovascular Pharmacology</pub><doi>10.1097/FJC.0000000000001416</doi></addata></record>
fulltext fulltext
identifier ISSN: 0160-2446
ispartof Journal of cardiovascular pharmacology, 2023-03
issn 0160-2446
language eng
recordid cdi_wolterskluwer_health_00005344-990000000-00159
source EZB-FREE-00999 freely available EZB journals
title Mavacamten – a targeted therapy for hypertrophic cardiomyopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T09%3A35%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wolterskluwer&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mavacamten%20%E2%80%93%20a%20targeted%20therapy%20for%20hypertrophic%20cardiomyopathy&rft.jtitle=Journal%20of%20cardiovascular%20pharmacology&rft.au=Schenk,%20Ashley&rft.date=2023-03-06&rft.issn=0160-2446&rft_id=info:doi/10.1097/FJC.0000000000001416&rft_dat=%3Cwolterskluwer%3E00005344-990000000-00159%3C/wolterskluwer%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true